AMYLIN PHARMACEUTICALS INC Accretion Expense
AMYLIN PHARMACEUTICALS INC reported Accretion Expense of $1.43 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC accretion expense for the quarter ending 2012-06-30 was $691.00K.
- AMYLIN PHARMACEUTICALS INC accretion expense for the quarter ending 2012-03-31 was $738.00K.
- AMYLIN PHARMACEUTICALS INC accretion expense for the quarter ending 2011-12-31 was $800.00K.
- AMYLIN PHARMACEUTICALS INC accretion expense for the quarter ending 2011-09-30 was $775.00K.
- AMYLIN PHARMACEUTICALS INC accretion expense for fiscal 2011 was $3.27M, a 22.49% increase from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC accretion expense for fiscal 2010 was $2.67M.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2012-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $1.43M 10-Q · filed 2012-08-03 | $2.23M derived: sum of 3 quarters · filed 2012-08-03 | $3.00M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $738.00K 10-Q · filed 2012-05-07 | $1.54M derived: sum of 2 quarters · filed 2012-05-07 | $2.31M derived: sum of 3 quarters · filed 2012-05-07 | |
| 2011-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $1.57M derived: sum of 2 quarters · filed 2012-02-22 | $3.27M 10-K · filed 2012-02-22 | |
| 2011-09-30 | $775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $2.47M 10-Q · filed 2011-10-28 | ||
| 2011-06-30 | $1.70M 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | $2.67M 10-K · filed 2012-02-22 |